[Skip to Content]
[Skip to Content Landing]
June 2012

Predicting Risk of Diabetic Retinopathy From Retinal Vessel Analysis: Personalized Medicine in Transition

Arch Ophthalmol. 2012;130(6):783-784. doi:10.1001/archophthalmol.2012.727

Despite significant advances in therapeutic strategies, diabetic retinopathy remains a leading cause of preventable vision loss among working-aged people in many developed countries.1 In the United States, about 1 in 4 diabetic patients has signs of retinopathy and 1 in 20 has vision-threatening retinopathy.2 Because early treatment is associated with better outcomes, clinicians routinely try to estimate a patient's risk of visual morbidity from diabetic retinopathy based on traditional risk factors (eg, diabetes duration, glycemic control, and blood pressure control) and retinopathy severity.